Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for inappropriate sinus tachycardia
2008-001201-42Phase 3Active
- Sponsor
- Policlinico San Donato
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ivabradine in inappropriate sinus tachycardia (IST) and sinus arrhythmia, sponsored by Policlinico San Donato. Primary endpoints: Mean heart rate reduction during ECG Holter monitoring and Orthostatic heart rate increase. Started Jul 2008; status: active.
02
Drugs
ivabradine
03
Conditions
inappropriate sinus tachycardia (IST)sinus arrhythmia
Beyond the preview
Go deeper on 2008-001201-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001201-42.